HF
GLMD icon

HRT Financial’s Galmed Pharmaceuticals GLMD Stock Holding History

HRT Financial’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23K Buy
+5,261
New +$26.2K ﹤0.01% 3909

Other funds holding GLMD

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's GLMD Position: Q2 2026 in Review

HRT Financial opened a new position in Galmed Pharmaceuticals (GLMD) in Q2 2026: 5,261 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #3909 among its holdings.

11 funds tracked by Wall St. Rank hold GLMD as of Q2 2026.

  • HRT Financial held 5,261 shares of Galmed Pharmaceuticals worth $23K as of Q2 2026.
  • Galmed Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • Galmed Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3909 holding.
  • 11 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.